Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

about

The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors.

P2860

Q35547514-1AFA6DC5-29CB-4720-8222-15721E9FBEFC Q37552014-BC91CBDF-79E9-41DD-959E-F45621D9A05B

P2860

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

Item

http://www.wikidata.org/entity/Q42134186

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@en

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@nl

type

Item

label

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@en

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@nl

prefLabel

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@en

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@nl

P1476

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

@en

P2093

B Perazzona

http://www.w3.org/2001/XMLSchema#string

H Lin

http://www.w3.org/2001/XMLSchema#string

R Arlinghaus

http://www.w3.org/2001/XMLSchema#string

T Sun

http://www.w3.org/2001/XMLSchema#string

Y Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The BCR gene encodes a novel serine/threonine kinase activity within a single exon

Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr

BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner

Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase

Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.

Jak2 is involved in c-Myc induction by Bcr-Abl.

Bcr is a negative regulator of the Wnt signalling pathway

Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.

Inhibition of Bcr serine kinase by tyrosine phosphorylation.

P2888

sj.onc.1210851

P304

2208-2214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1210851

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5909893

http://www.w3.org/2001/XMLSchema#string

P6179

1035406432

http://www.w3.org/2001/XMLSchema#string

P698

17934518

http://www.w3.org/2001/XMLSchema#string

P932

2585769

http://www.w3.org/2001/XMLSchema#string

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

about

P2860

P2860

Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P932